Jun 16, 2022 / 08:00AM GMT
Operator
Good day, ladies and gentlemen, and welcome to Syncona's full year results for 2021-2022 financial year. (Operator Instructions) I'd like to advise all participants that this call is being recorded.
I will now hand over to the CEO of Syncona Limited, Martin Murphy, to open the presentation. Martin, please go ahead.
Martin Patrick Murphy - Syncona Limited - CEO
Good morning, and welcome to Syncona's annual results. Before we step into the specifics of last year, I'd like to just step back and look at what we've achieved over the last 10 years. Syncona was founded back in 2012. And at that time, we set out with a very ambitious plan to transform the way in which innovative life science technology in the U.K. was commercialized through company creation and to thereby deliver economic returns and innovative new treatments for patients.
Since 2012, we've built 18 companies. We've delivered over GBP 900 million with attractive returns. And from a patient perspective, we've taken 3 products into pivotal trials, which is the last trial prior to
Full Year 2022 Syncona Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot